𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET

✍ Scribed by R. Hilker; J. Voges; A. Thiel; M. Ghaemi; K. Herholz; V. Sturm; W.-D. Heiss

Publisher
Springer
Year
2002
Tongue
English
Weight
99 KB
Volume
109
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differential effects of levodopa and sub
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease
✍ Lars Timmermann; Martin Braun; Stefan Groiss; Lars Wojtecki; Stefan Ostrowski; H πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 574 KB

Cardinal symptoms of Parkinson's disease (PD) respond well to treatment with levodopa and deep brain stimulation (DBS) of the subthalamic nucleus (STN). However, it has remained unclear whether levodopa and STN-DBS have differential effects on bradykinesia. We investigated 8 PD-patients with STN-ele

Expectation and the placebo effect in Pa
Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation
✍ Rodrigo Mercado; Constantine Constantoyannis; Tomasz Mandat; Ajit Kumar; Michael πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract To determine whether the degree to which a patient with Parkinson's disease expects therapeutic benefit from subthalamic nucleus–deep brain stimulation (STN‐DBS) influences the magnitude of his or her improved motor response, 10 patients with idiopathic Parkinson's and bilateral STN‐DBS